Trials / Completed
CompletedNCT00502775
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 680 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to compare nighttime symptom relief of fluticasone furoate nasal spray versus oral fexofenadine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluticasone furoate, fexofenadine |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2007-07-18
- Last updated
- 2016-12-09
- Results posted
- 2009-03-20
Locations
42 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00502775. Inclusion in this directory is not an endorsement.